Item


Study of the use of medicines for the treatment of attention deficit and hyperactivity disorder in Catalonia

Hypothesis: This is a descriptive study for which no hypothesis has been formulated. Objectives: 1- To determine the prevalence of consumption of drugs authorized for the treatment of ADHD in Catalonia. 2- To know sociodemographic and clinical characteristics of patients receiving treatment with drugs authorized for ADHD in Catalonia. 3- To evaluate the follow-up degree of the use recommendations these drugs to the recommendations of the technical file. 4- To study the drug consumption evolution for the treatment of ADHD in the period comprised between 2010 and 2015, in Catalonia and Girona. Material and Methods: Two studies of drug use were carried out. The first one addressed the objectives 1-3 and the second one the number 4. Design: A descriptive cross-sectional study was carried out. Study population: Patients receiving treatment with methylphenidate (MPH), lisdexamphetamine (LDX) or atomoxetine (ATX) sometime in 2015 was obtained

Manager: Mayoral, Sacramento
Castells Cervell贸, Xavier
Other contributions: Universitat de Girona. Facultat de Medicina
Author: V谩zquez Casar, Marta
Date: 2017 February
Abstract: Hypothesis: This is a descriptive study for which no hypothesis has been formulated. Objectives: 1- To determine the prevalence of consumption of drugs authorized for the treatment of ADHD in Catalonia. 2- To know sociodemographic and clinical characteristics of patients receiving treatment with drugs authorized for ADHD in Catalonia. 3- To evaluate the follow-up degree of the use recommendations these drugs to the recommendations of the technical file. 4- To study the drug consumption evolution for the treatment of ADHD in the period comprised between 2010 and 2015, in Catalonia and Girona. Material and Methods: Two studies of drug use were carried out. The first one addressed the objectives 1-3 and the second one the number 4. Design: A descriptive cross-sectional study was carried out. Study population: Patients receiving treatment with methylphenidate (MPH), lisdexamphetamine (LDX) or atomoxetine (ATX) sometime in 2015 was obtained
Format: application/pdf
Document access: http://hdl.handle.net/10256/14303
Language: eng
Collection: Medicina (TFG)
Rights: Attribution-NonCommercial-NoDerivs 3.0 Spain
Rights URI: http://creativecommons.org/licenses/by-nc-nd/3.0/es/
Subject: Trastorn per d猫ficit d鈥檃tenci贸 amb hiperactivitat -- Tractament
Attention-deficit hiperactivity disorder -- Treatment
Neuropsicofarmacologia
Neuropsychopharmacology
Title: Study of the use of medicines for the treatment of attention deficit and hyperactivity disorder in Catalonia
Type: info:eu-repo/semantics/bachelorThesis
Repository: DUGiDocs

Subjects

Authors